ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ABOS Acumen Pharmaceuticals Inc

3.49
0.01 (0.29%)
04 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -8.42M-9.21M-10.41M-11.37M-14.25M-13.14M-13.48M-16.04M
Pre Tax Income -8.35M-9.13M-10.15M-10.71M-12.87M-11.31M-11.61M-12.96M
Net Income -8.35M-9.13M-10.15M-10.71M-12.87M-11.31M-11.61M-12.96M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -8.41M-9.21M-10.41M-11.37M-14.26M-13.14M-13.49M-16.08M
EBITDA -8.41M-9.2M-10.41M-11.36M-14.24M-13.12M-13.46M-16.03M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.7M1.44M000
Operating Income -7.81M-7.91M-19.58M-45.24M-61.14M
Pre Tax Income -7.91M-7.33M-100.61M-42.86M-52.37M
Net Income -7.69M-7.33M-100.61M-42.86M-52.37M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -18.344-17.482-2.083-0.619-0.608
EBIT -7.95M-7.33M-19.53M-45.25M-61.22M
EBITDA -7.81M-7.91M-19.58M-45.21M-61.08M

Your Recent History

Delayed Upgrade Clock